Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on June 30 20262. Take note of the Notice of Disclosure of Interest and Intimation u/s 164 of the Companies Act 20133. Take note of Declarations from Independent Directors U/S 149(7) of The Companies Act 20134. Any other business with the permission of the chair
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
